Predict your next investment

HEALTHCARE | Drug Development
aerami.com

See what CB Insights has to offer

Business Relationships

3

Aerami Therapeutics Partners & Customers

3 Partners and customers

Aerami Therapeutics has 3 strategic partners and customers. Aerami Therapeutics recently partnered with Vectura Group on June 6, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

6/8/2020

Licensor

Vectura Group

United Kingdom

Contract Pharma Staff06.08.20. Vectura Signs Agreement with Aerami Therapeutics. Vectura Signs Agreement With Aerami Therapeutics - Contract Pharma

Under the partnership , Vectura Group will receive development fees , revenue from the provision of Fox nebulizer devices and mid-single digit royalties from global net sales of imatinib , together with regulatory and success-related milestone payments .

1

9/11/2019

Partner

DarioHealth

United States

Subscribe to see more

Subscribe to see more

10

12/4/2017

Partner

Phillips-Medisize

United States

Subscribe to see more

Subscribe to see more

10

Date

6/8/2020

9/11/2019

12/4/2017

Type

Licensor

Partner

Partner

Business Partner

Vectura Group

DarioHealth

Phillips-Medisize

Country

United Kingdom

United States

United States

News Snippet

Contract Pharma Staff06.08.20. Vectura Signs Agreement with Aerami Therapeutics. Vectura Signs Agreement With Aerami Therapeutics - Contract Pharma

Under the partnership , Vectura Group will receive development fees , revenue from the provision of Fox nebulizer devices and mid-single digit royalties from global net sales of imatinib , together with regulatory and success-related milestone payments .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.